A chemical compound that has had one or more of its atoms replaced by a radionuclide is known as a Radioactive Tracer, radiotracer, or radioactive label. Because of its radioactive decay, radioactive tracer compounds can be used to investigate the mechanism of chemical reactions by tracing the path that the radioisotope takes from reactants to products. Thus, the radioactive version of isotopic labelling is radiolabelling or radiotracing. The use of radioactive tracers is commonly referred to as radioisotope feeding experiments in biological contexts. It has been extensively used to follow the course of biological reactions to employ radioisotopes of hydrogen, carbon, phosphorus, sulfur, and iodine. A radioactive tracer can also be employed as a flow tracer or to monitor a substance's distribution inside a natural system like a cell or tissue. In the process of producing natural gas, radioactive tracers are also utilised to locate cracks caused by hydraulic fracturing. A number of imaging methods, including technetium scans, SPECT scans, and PET scans, are based on radioactive tracers. Carbon-14, an isotope that occurs naturally, is used in radiocarbon dating as an isotopic label.
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami, United States
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, University of Alberta, Canada
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : R&D consultancy at the medicines discovery catapult: De-risking drug discovery for innovators
Adriana Gambardella, Medicine Discovery Catapult, United Kingdom
Title : Biocompatible synthesis of non crystalline iron oxide nanoparticles with stable colloidal properties
Lan Wang, Paretor LLC, United States
Title : Precision diagnostics: Effectiveness of innovative imaging technologies for early detection of lung cancers
Huiqin Yang, ICON Clinical Research Ltd, United Kingdom
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Design and characterization of gum arabic buccal films for protein drug delivery
Krisztian Pamlenyi, University of Szeged, Hungary